Dae Ho Lee

9.5k total citations · 1 hit paper
210 papers, 6.4k citations indexed

About

Dae Ho Lee is a scholar working on Oncology, Pathology and Forensic Medicine and Molecular Biology. According to data from OpenAlex, Dae Ho Lee has authored 210 papers receiving a total of 6.4k indexed citations (citations by other indexed papers that have themselves been cited), including 88 papers in Oncology, 47 papers in Pathology and Forensic Medicine and 44 papers in Molecular Biology. Recurrent topics in Dae Ho Lee's work include Lymphoma Diagnosis and Treatment (42 papers), Cancer Immunotherapy and Biomarkers (27 papers) and Lung Cancer Treatments and Mutations (21 papers). Dae Ho Lee is often cited by papers focused on Lymphoma Diagnosis and Treatment (42 papers), Cancer Immunotherapy and Biomarkers (27 papers) and Lung Cancer Treatments and Mutations (21 papers). Dae Ho Lee collaborates with scholars based in South Korea, United States and Spain. Dae Ho Lee's co-authors include Kilwon Cho, Cheolwon Suh, Sang‐Hoon Lee, Seung Goo Lee, Sang‐We Kim, Ho Sun Lim, Jooryung Huh, Ji‐Youn Han, Joong Tark Han and Chang Y. Ryu and has published in prestigious journals such as Journal of the American Chemical Society, Advanced Materials and Journal of Biological Chemistry.

In The Last Decade

Dae Ho Lee

204 papers receiving 6.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Tiragolumab plus atezolizumab versus placebo plus atezolizumab as a first-line treatment for PD-L1-selected non-small-cell lung cancer (CITYSCAPE): primary and follow-up analyses of a randomised, double-blind, phase 2 study

2022 296 citations Byoung Chul Cho, Delvys Rodríguez‐Abreu et al. The Lancet Oncology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Dae Ho Lee South Korea	42	2.3k	1.3k	1.2k	929	894	210	6.4k
Hiroaki Kajiyama Japan	50	2.4k 1.0×	3.2k 2.4×	365 0.3×	960 1.0×	507 0.6×	423	10.3k
Jeong Hyeon Lee South Korea	42	1.4k 0.6×	1.8k 1.3×	768 0.6×	794 0.9×	499 0.6×	283	6.8k
Hiroshi Inagaki Japan	51	2.2k 0.9×	1.0k 0.8×	1.9k 1.6×	728 0.8×	774 0.9×	393	10.0k
Fumitaka Kikkawa Japan	60	3.1k 1.3×	4.5k 3.3×	507 0.4×	1.2k 1.3×	524 0.6×	552	15.4k
M. Landthaler Germany	44	840 0.4×	1.1k 0.8×	361 0.3×	1.1k 1.1×	1.0k 1.1×	243	7.8k
Akihiro Sato Japan	47	1.7k 0.7×	938 0.7×	455 0.4×	1.4k 1.5×	646 0.7×	303	6.8k
Yifan Wang China	37	2.4k 1.0×	3.0k 2.3×	420 0.4×	870 0.9×	946 1.1×	194	7.1k
Hui Gan Australia	46	2.4k 1.0×	1.9k 1.4×	361 0.3×	1.2k 1.2×	534 0.6×	326	7.5k
Donald M. Salter United Kingdom	45	990 0.4×	2.0k 1.5×	483 0.4×	777 0.8×	1.2k 1.3×	165	8.8k
Michael Landthaler Germany	58	2.3k 1.0×	2.4k 1.8×	597 0.5×	1.9k 2.0×	1.5k 1.7×	303	11.1k

Countries citing papers authored by Dae Ho Lee

Since Specialization

Citations

This map shows the geographic impact of Dae Ho Lee's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dae Ho Lee with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dae Ho Lee more than expected).

Fields of papers citing papers by Dae Ho Lee

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dae Ho Lee. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dae Ho Lee. The network helps show where Dae Ho Lee may publish in the future.

Co-authorship network of co-authors of Dae Ho Lee

This figure shows the co-authorship network connecting the top 25 collaborators of Dae Ho Lee. A scholar is included among the top collaborators of Dae Ho Lee based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dae Ho Lee. Dae Ho Lee is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Choi, Hojung, Han‐Joo Maeng, Young‐Bum Kim, et al.. (2025). The dual targeting effects of KD025 on casein kinase 2 and ROCK2 in a mouse model of diet-induced obesity. Biochemical Pharmacology. 237. 116933–116933.

Jung, Seung Eun, et al.. (2024). Influence on the Physico-Chemical Qualities of Emulsified Sausages Added Different Levels of <i>Tenebrio Molitor</i> L. Powder. Journal of Agriculture & Life Science. 58(1). 51–60. 4 indexed citations

Reck, Martin, Fabrice Barlési, James C. Yang, et al.. (2023). Avelumab Versus Platinum-Based Doublet Chemotherapy as First-Line Treatment for Patients With High-Expression Programmed Death-Ligand 1–Positive Metastatic NSCLC: Primary Analysis From the Phase 3 JAVELIN Lung 100 Trial. Journal of Thoracic Oncology. 19(2). 297–313. 9 indexed citations

Barlési, Fabrice, Nicolás Isambert, Enriqueta Felip, et al.. (2022). Bintrafusp Alfa, a Bifunctional Fusion Protein Targeting TGF-β and PD-L1, in Patients with Non-Small Cell Lung Cancer Resistant or Refractory to Immune Checkpoint Inhibitors. The Oncologist. 28(3). 258–267. 25 indexed citations

Cho, Byoung Chul, Delvys Rodríguez‐Abreu, Maen Hussein, et al.. (2022). Tiragolumab plus atezolizumab versus placebo plus atezolizumab as a first-line treatment for PD-L1-selected non-small-cell lung cancer (CITYSCAPE): primary and follow-up analyses of a randomised, double-blind, phase 2 study. The Lancet Oncology. 23(6). 781–792. 296 indexed citations breakdown →

Jeong, Hyehyun, Hyungwoo Cho, Jung Yong Hong, et al.. (2022). Modified Stage Grouping of Diffuse Large B-Cell Lymphoma Involving the Same Side of the Diaphragm in the Rituximab Era. Frontiers in Oncology. 12. 888925–888925.

Lee, Jin Sook, et al.. (2018). Comparison of Microbiota Variation in Korean Healthy Adolescents with Adults Suggests Notable Maturity Differences. OMICS A Journal of Integrative Biology. 22(12). 770–778. 4 indexed citations

Yang, Hannah, Mi-Hee Lee, Intae Park, et al.. (2017). HSP90 inhibitor (NVP-AUY922) enhances the anti-cancer effect of BCL-2 inhibitor (ABT-737) in small cell lung cancer expressing BCL-2. Cancer Letters. 411. 19–26. 26 indexed citations

Kim, Ok‐Hee, Hyojung Kim, Dongki Yang, et al.. (2017). Impaired phagocytosis of apoptotic cells causes accumulation of bone marrow-derived macrophages in aged mice. BMB Reports. 50(1). 43–48. 22 indexed citations

10.

Lee, Seung‐Hong, Seok‐Chun Ko, Mincheol Kang, Dae Ho Lee, & You‐Jin Jeon. (2016). Octaphlorethol A, a marine algae product, exhibits antidiabetic effects in type 2 diabetic mice by activating AMP-activated protein kinase and upregulating the expression of glucose transporter 4. Food and Chemical Toxicology. 91. 58–64. 46 indexed citations

11.

Choi, Joon‐Seok, Jun Ki Kim, Yoon Jung Yang, et al.. (2015). Identification of cromolyn sodium as an anti-fibrotic agent targeting both hepatocytes and hepatic stellate cells. Pharmacological Research. 102. 176–183. 15 indexed citations

12.

Kim, Ho Cheol, Joon Seon Song, Jae Cheol Lee, et al.. (2014). Clinical significance of NQO1 polymorphism and expression of p53, SOD2, PARP1 in limited-stage small cell lung cancer.. PubMed. 7(10). 6743–51. 9 indexed citations

13.

Chang, Youjin, Jin Won Huh, Sang‐Bum Hong, et al.. (2014). Outcomes and prognostic factors of patients with lung cancer and pneumonia-induced respiratory failure in a medical intensive care unit: A single-center study. Journal of Critical Care. 29(3). 414–419. 10 indexed citations

14.

Keam, Bhumsuk, Young Ho Yun, Dae Seog Heo, et al.. (2012). The attitudes of Korean cancer patients, family caregivers, oncologists, and members of the general public toward advance directives. Supportive Care in Cancer. 21(5). 1437–1444. 51 indexed citations

15.

Lee, Dae Ho, et al.. (2011). Internet Pricing and Network Neutrality: How Internet Pricing Schemes Affect the Incentives of Internet Service Providers. SSRN Electronic Journal. 18(1). 17–44. 3 indexed citations

16.

Lee, Seung Goo, et al.. (2010). Switchable Transparency and Wetting of Elastomeric Smart Windows. Advanced Materials. 22(44). 5013–5017. 278 indexed citations

17.

Yoon, Sun Och, Cheolwon Suh, Dae Ho Lee, et al.. (2010). Distribution of lymphoid neoplasms in the Republic of Korea: Analysis of 5318 cases according to the World Health Organization classification. American Journal of Hematology. 85(10). 760–764. 106 indexed citations

18.

Jo, Jae‐Cheol, Dae Ho Lee, Ho June Song, et al.. (2008). Infarction and Perforation of the Small Intestine due to Tumor Emboli from Disseminated Rectal Cancer. Gut and Liver. 2(2). 130–132. 3 indexed citations

19.

Kang, Dae Gill, Ming Yin, Hyuncheol Oh, Dae Ho Lee, & Ho Sub Lee. (2004). Vasorelaxation by Amentoflavone Isolated fromSelaginella tamariscina. Planta Medica. 70(8). 718–722. 34 indexed citations

20.

Krauss, Daniel A. & Dae Ho Lee. (2003). Deliberating on dangerousness and death: jurors' ability to differentiate between expert actuarial and clinical predictions of dangerousness. International Journal of Law and Psychiatry. 26(2). 113–137. 37 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact